DENVER — An eclectic crowd of thousands — podcasters, marketers, start-ups, seekers — invaded a psychedelics conference in Denver this week to experience everything from a dimly lit room filled with kaleidoscope art and an extensive speaker lineup, from a former Republican Governor to star NFL quarterback Aaron Rodgers.
The conference, organized by a psychedelic advocacy group, came months after Colorado voters decided to join Oregon in decriminalizing psychedelic mushrooms. Although it is a sign of growing cultural acceptance For substances that advocates say may offer benefits for things like post-traumatic stress disorder and alcoholism, medical experts warn that more research is needed into the efficacy of the drugs and the extent of the risks of psychedelics, which can cause hallucinations.
Rodgers, who will soon be making his New York Jets debut after years with the Green Bay Packers, spoke Wednesday night with podcaster Aubrey Marcus. Rodgers described taking ayahuasca with his teammates as “a radical life changer” and stated that many other professional athletes have reached out to him.
“I found a deeper self-love,” Rodgers said of his ayahuasca experience. “It unlocked that whole world of what I’m really here to do is connect, connect with those guys and make those bonds and inspire people.”
The conference’s host organization, the Multidisciplinary Association for Psychedelic Studies, is the largest advocacy group in the United States. It has strategized to reach across the political spectrum, said Nicolas Langlitz, a science historian who has researched the rise and fall of psychedelic movements.
“The moment any issue becomes politically polarizing, ironically these super polarizing substances now garner bipartisan support,” Langlitz said. Still, he added, the conference is “purely designed to promote hype.”
“Any kind of overselling is not good for science because science needs to be accurate rather than force things,” he said. “It’s compensation. (The conference) generates interest, ultimately generates more research, although the research could be biased towards positive results.”
Psychedelics are federally illegal, although acceptance and interest in studying their potential benefits has increased. For example, some researchers believe that psilocybin, the compound in psychedelic mushrooms, change the shape the brain organizes itself and can help users overcome things like depression and alcoholism.
The drugs themselves, and the interest in them, are not new. In the middle of the last century, Aldous Huxley, Timothy Leary, and Ken Kesey helped fuel the use of psychedelics during the counterculture movement, and optimism was running high among some psychologists about the potential of the drugs.
But the Nixon administration criminalized psychedelics, driving them underground.
“In both cases, you have this surge of exuberance that may or may not be irrational,” said author Michael Pollan, who has written a book on psychedelics and will speak at the conference. “But I think a big difference (now) is that the enthusiasm for the potential of psychedelics affects a much more representative portion of the population, it’s not a counterculture.”
republican strongholds, including Utah and Missouri, have or are considering commissioning studies on drugs, in part inspired by veterans’ stories. Former Texas Republican Governor Rick Perry spoke Wednesday about helping pass a bill in the Texas Legislature in 2021 to fund a study of psilocybin for veterans, though he does not support recreational use. In Congress, similar veteran-focused proposals brought progressive Democratic Rep. Alexandria Ocasio-Cortez of New York and far-right Rep. Matt Gaetz of Florida into an unlikely alignment.
Public interest also appears to be growing. Just six years ago in Oakland, California, the Multidisciplinary Association for Psychedelic Studies held a conference with approximately 3,000 attendees and some lesser-known speakers and staunch advocates.
This time, the organizers estimate at least 10,000 attendees. Other famous speakers will include former NHL player Daniel Carcillo, owner of a company specializing in psychedelic therapies; Olympic silver medalist figure skater Sasha Cohen; rapper and actor Jaden Smith; comedians Reggie Watts and Eric Andre, Andrew Huberman, a top 10 podcaster; and Carl Hart, chair of the psychology department at Columbia University.
Recruiting that celebrity support for psychedelics is part of MAPS’ public relations strategy, founder Rick Doblin said. Asked if the platform of a non-expert like Rodgers could mislead the public, Doblin demurred, adding that it would be “dangerous” for anyone to claim there are no risks in taking psychedelics.
Doblin said that taking MDMA should occur “only under the direct supervision of a therapist, it’s never a take-home medication.” He also emphasized what many speakers echoed on the first day about psychedelics paired with mental health professionals: “The treatment is not the drug, it’s the therapy that the drug makes most effective.”
That was a more tempered approach than his introductory speech, when, before a packed theater, Doblin espoused grandiose goals like “net zero” trauma by 2070 through the use of psychedelics.
The American Psychiatric Association has not endorsed the use of psychedelics in treatment, noting that the Food and Drug Administration has yet to offer a final determination. The FDA designated psilocybin a “breakthrough therapy” in 2018, a label designed to speed the development and review of drugs to treat a serious condition. MDMA, often called ecstasy, also has that designation for the treatment of PTSD.
Both Pollan and Langlitz believe further research is key, especially as the nation faces an unprecedented mental health crisis and people struggle to find the right treatment. But, Langlitz said, it’s important to let the research shape the narrative.
“I would just try to keep my mind open to the possibility that, in retrospect, we tell a very different story than the protagonists of psychedelic therapies are currently predicting,” he said.



